PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 79 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $41,000 | -92.7% | 68,012 | -92.1% | 0.00% | – |
| Q1 2017 | $562,000 | +778.1% | 859,500 | +327.2% | 0.00% | – |
| Q4 2016 | $64,000 | +2033.3% | 201,174 | +2280.8% | 0.00% | – |
| Q3 2016 | $3,000 | +200.0% | 8,450 | +70.8% | 0.00% | – |
| Q2 2016 | $1,000 | -96.9% | 4,948 | -93.5% | 0.00% | – |
| Q1 2016 | $32,000 | -91.9% | 76,157 | -77.5% | 0.00% | – |
| Q4 2015 | $396,000 | +71.4% | 338,972 | +49.2% | 0.00% | – |
| Q3 2015 | $231,000 | +156.7% | 227,143 | +231.8% | 0.00% | – |
| Q2 2015 | $90,000 | +38.5% | 68,466 | +42.1% | 0.00% | – |
| Q1 2015 | $65,000 | -65.1% | 48,174 | -64.0% | 0.00% | – |
| Q4 2014 | $186,000 | +200.0% | 133,800 | +196.3% | 0.00% | – |
| Q3 2014 | $62,000 | +1.6% | 45,158 | +39.6% | 0.00% | – |
| Q2 2014 | $61,000 | -79.3% | 32,345 | -79.1% | 0.00% | – |
| Q1 2014 | $294,000 | +988.9% | 154,713 | +701.2% | 0.00% | – |
| Q4 2013 | $27,000 | -12.9% | 19,311 | -12.5% | 0.00% | – |
| Q3 2013 | $31,000 | – | 22,065 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAXTER BROS INC | 170,506 | $232,000 | 0.09% |
| First Heartland Consultants, Inc. | 86,204 | $117,000 | 0.05% |
| Rotella Capital Management, Inc. | 20,769 | $28,000 | 0.03% |
| FIDGEON TIMOTHY F | 33,000 | $45,000 | 0.02% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 547,800 | $746,000 | 0.02% |
| Freedom Investment Management, Inc. | 74,127 | $101,000 | 0.02% |
| Investors Capital Advisory Services | 63,288 | $86,000 | 0.02% |
| REYNOLDS CAPITAL MANAGEMENT LLC | 10,000 | $14,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 76,914 | $104,000 | 0.01% |
| PINNACLE FINANCIAL PARTNERS INC | 20,000 | $27,000 | 0.01% |